Advertisement

Topics

Onxeo Sells Two Oral Pathology Treatments to Vectans Pharma

08:10 EDT 2 Aug 2017 | PharmPro

Onxeo divests two non-core products in oral pathologies to Vectans Pharma.
Contributed Author: 
Business Wire
Topics: 

Original Article: Onxeo Sells Two Oral Pathology Treatments to Vectans Pharma

NEXT ARTICLE

More From BioPortfolio on "Onxeo Sells Two Oral Pathology Treatments to Vectans Pharma"

Quick Search
Advertisement